VA Personalis Q3 Revenues Down 33 Percent on Disputed VA Contract The revenue drop reflects a hold on the company's ongoing contract to provide sequencing services for the US Department of Veterans Affairs. Natera Awarded Contract to Provide Cancer Testing Services to VA Natera will provide the VA with its Signatera circulating tumor DNA test for minimal residual disease assessment and treatment monitoring. Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests The company's full lung cancer diagnostic menu will be covered for eligible veterans, active-duty military, and their families. Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery. Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test Grail will make Galleri available to 10,000 veterans, who may then participate in the company's observational REFLECTION study. May 6, 2022 Tempus to Provide NGS Cancer Tests to US Department of Veterans Affairs Apr 29, 2022 Castle Biosciences, VHA Expand Supply Contract to Cover Full Skin Cancer Test Portfolio Apr 28, 2022 Million Veteran Program Study Links Genetic Variants Related to Severe COVID-19 to Other Conditions Apr 18, 2022 Clinical Polygenic Risk Assay, Reporting Pipeline Shows Promise for Multiple Conditions Premium Feb 22, 2022 Million Veterans Study Yields Prostate Cancer Risk Score With Promise for Improved Screening Premium Jan 7, 2022 Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent Aug 24, 2021 Castle Biosciences Awarded VA Supply Contract for Melanoma Test Aug 4, 2021 Personalis Q2 Revenues Rise 11 Percent May 5, 2021 Personalis Q1 Revenues Grow 9 Percent Apr 22, 2021 Renalytix AI Lands US Government Contract for Kidney Disease Test Jan 28, 2021 Million Veteran Program GWAS Uncovers Genetic Loci Linked to PTSD Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Nov 5, 2020 Personalis Q3 Revenues Up 16 Percent Aug 21, 2020 Single-Cell Analysis Reveals Ulcerative Colitis Tissue, Immune Features Aug 6, 2020 Personalis Q2 Revenues Up 23 Percent May 7, 2020 Personalis Q1 Revenues Up 36 Percent May 7, 2020 Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening Premium Jan 7, 2020 Anxiety GWAS On Million Veteran Program Data Uncovers New Loci Nov 13, 2019 Personalis Q3 Revenues Up 47 Percent Oct 9, 2019 PTSD GWAS Meta-Analysis Leads to Identification of Ancestry, Sex-Specific Risk Loci Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.